As the closely-watched opioid litigation in Ohio nears its first trial, Endo has struck a $10 million settlement and Allergan is said to be nearing its own deal.
While opioid drugmakers have been sued plenty of times before, this week’s lawsuit from Ohio may prove a genuine threat to the companies involved, according to one influential analyst.